CURX

CURANEX PHARMACEUTICALS INC

CURX·23126K106·US·Common Stock·Healthcare - Biotechnology

CURX (CURANEX PHARMACEUTICALS INC) is held by 6 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($56,820), XTX Topco Ltd ($26,224), CITADEL ADVISORS LLC ($25,851). Net institutional sentiment: Bearish.

6
Holders
Avg rating(1 Elite)
$133,220
Total Value
30% (10)
Fund Consensus
3 buying - 7 selling

No verdict yet — fewer than 2 funds hold CURX.

13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
111,130(+495.2%)$56,8200.0%-57.31%
23
Increased
51,289(+21.0%)$26,2240.0%-39.02%
23
Decreased
50,559(-51.5%)$25,8510.0%-64.31%
0
Decreased
20,254(-66.8%)$10,3560.0%-35.29%
0
New
19,332$9,8840.0%-52.17%
26
Decreased
7,995(-38.5%)$4,0850.0%-72.15%
0
Exited
0(-100.0%)$110.0%+35.29%
0
Exited
0(-100.0%)$8,2620.0%-41.77%
0
Exited
0(-100.0%)$4,0000.0%+35.29%
0
Exited
0(-100.0%)$19,6040.0%+35.29%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used